139 related articles for article (PubMed ID: 8184910)
1. BQ123, an ETA-receptor antagonist, attenuates hypoxic pulmonary hypertension in rats.
Bonvallet ST; Zamora MR; Hasunuma K; Sato K; Hanasato N; Anderson D; Sato K; Stelzner TJ
Am J Physiol; 1994 Apr; 266(4 Pt 2):H1327-31. PubMed ID: 8184910
[TBL] [Abstract][Full Text] [Related]
2. [Effects of endothelin receptor antagonist on the hypoxic pulmonary hypertension].
Chen W; Cheng D
Hua Xi Yi Ke Da Xue Xue Bao; 2000 Sep; 31(3):370-2, 386. PubMed ID: 12545837
[TBL] [Abstract][Full Text] [Related]
3. ETA-receptor antagonist prevents and reverses chronic hypoxia-induced pulmonary hypertension in rat.
DiCarlo VS; Chen SJ; Meng QC; Durand J; Yano M; Chen YF; Oparil S
Am J Physiol; 1995 Nov; 269(5 Pt 1):L690-7. PubMed ID: 7491990
[TBL] [Abstract][Full Text] [Related]
4. BQ123, an ETA receptor antagonist, attenuates endothelin-1-induced vasoconstriction in rat pulmonary circulation.
Bonvallet ST; Oka M; Yano M; Zamora MR; McMurtry IF; Stelzner TJ
J Cardiovasc Pharmacol; 1993 Jul; 22(1):39-43. PubMed ID: 7690094
[TBL] [Abstract][Full Text] [Related]
5. [Adenosine receptors agonists mitigated PAH of rats induced by chronic hypoxia through reduction of renin activity/angiotensin II levels and increase of inducible nitric oxide synthase-nitric oxide levels].
Tan JX; Huang XL; Wang B; Fang X; Huang DN
Zhonghua Er Ke Za Zhi; 2012 Oct; 50(10):782-7. PubMed ID: 23302571
[TBL] [Abstract][Full Text] [Related]
6. ZD1611, an orally active endothelin-A receptor antagonist, prevents chronic hypoxia-induced pulmonary hypertension in the rat.
Bialecki RA; Fisher CS; Abbott BM; Barthlow HG; Caccese RG; Stow RB; Rumsey J; Rumsey W
Pulm Pharmacol Ther; 1999; 12(5):303-12. PubMed ID: 10545286
[TBL] [Abstract][Full Text] [Related]
7. Endothelin-A receptor antagonist prevents acute hypoxia-induced pulmonary hypertension in the rat.
Oparil S; Chen SJ; Meng QC; Elton TS; Yano M; Chen YF
Am J Physiol; 1995 Jan; 268(1 Pt 1):L95-100. PubMed ID: 7840234
[TBL] [Abstract][Full Text] [Related]
8. Role of angiotensin-converting enzyme and angiotensin II in development of hypoxic pulmonary hypertension.
Morrell NW; Morris KG; Stenmark KR
Am J Physiol; 1995 Oct; 269(4 Pt 2):H1186-94. PubMed ID: 7485548
[TBL] [Abstract][Full Text] [Related]
9. Pulmonary vascular pressure effects by endothelin-1 in normoxia and chronic hypoxia: a longitudinal study.
Tjen-A-Looi S; Ekman R; Osborn J; Keith I
Am J Physiol; 1996 Dec; 271(6 Pt 2):H2246-53. PubMed ID: 8997280
[TBL] [Abstract][Full Text] [Related]
10. [The effect of ETA receptor antagonist WS009A on the pathogenesis of hypoxic pulmonary hypertension in rats].
Yang X; Chen W
Hua Xi Yi Ke Da Xue Xue Bao; 2001 Sep; 32(3):409-12. PubMed ID: 12536579
[TBL] [Abstract][Full Text] [Related]
11. Effect of SB 217242 on hypoxia-induced cardiopulmonary changes in the high altitude-sensitive rat.
Underwood DC; Bochnowicz S; Osborn RR; Luttmann MA; Louden CS; Hart TK; Elliott JD; Hay DW
Pulm Pharmacol Ther; 1999; 12(1):13-26. PubMed ID: 10208832
[TBL] [Abstract][Full Text] [Related]
12. Exogenous ghrelin attenuates the progression of chronic hypoxia-induced pulmonary hypertension in conscious rats.
Schwenke DO; Tokudome T; Shirai M; Hosoda H; Horio T; Kishimoto I; Kangawa K
Endocrinology; 2008 Jan; 149(1):237-44. PubMed ID: 17916633
[TBL] [Abstract][Full Text] [Related]
13. Involvement of endothelin-1 in hypoxic pulmonary vasoconstriction in the lamb.
Wang Y; Coe Y; Toyoda O; Coceani F
J Physiol; 1995 Jan; 482 ( Pt 2)(Pt 2):421-34. PubMed ID: 7714833
[TBL] [Abstract][Full Text] [Related]
14. Endothelin-1 and serotonin are involved in activation of RhoA/Rho kinase signaling in the chronically hypoxic hypertensive rat pulmonary circulation.
Homma N; Nagaoka T; Morio Y; Ota H; Gebb SA; Karoor V; McMurtry IF; Oka M
J Cardiovasc Pharmacol; 2007 Dec; 50(6):697-702. PubMed ID: 18091588
[TBL] [Abstract][Full Text] [Related]
15. Endothelin-1 receptor antagonist BQ123 prevents pulmonary artery hypertension induced by low ambient temperature in broilers.
Yang Y; Qiao J; Wu Z; Chen Y; Gao M; Ou D; Wang H
Biol Pharm Bull; 2005 Dec; 28(12):2201-5. PubMed ID: 16327149
[TBL] [Abstract][Full Text] [Related]
16. Exercise training improves lung gas exchange and attenuates acute hypoxic pulmonary hypertension but does not prevent pulmonary hypertension of prolonged hypoxia.
Favret F; Henderson KK; Allen J; Richalet JP; Gonzalez NC
J Appl Physiol (1985); 2006 Jan; 100(1):20-5. PubMed ID: 16179398
[TBL] [Abstract][Full Text] [Related]
17. PAF antagonists inhibit pulmonary vascular remodeling induced by hypobaric hypoxia in rats.
Ono S; Westcott JY; Voelkel NF
J Appl Physiol (1985); 1992 Sep; 73(3):1084-92. PubMed ID: 1400021
[TBL] [Abstract][Full Text] [Related]
18. E-4010, a selective phosphodiesterase 5 inhibitor, attenuates hypoxic pulmonary hypertension in rats.
Hanasato N; Oka M; Muramatsu M; Nishino M; Adachi H; Fukuchi Y
Am J Physiol; 1999 Aug; 277(2):L225-32. PubMed ID: 10444515
[TBL] [Abstract][Full Text] [Related]
19. Protection from pulmonary hypertension with an orally active endothelin receptor antagonist in hypoxic rats.
Eddahibi S; Raffestin B; Clozel M; Levame M; Adnot S
Am J Physiol; 1995 Feb; 268(2 Pt 2):H828-35. PubMed ID: 7864210
[TBL] [Abstract][Full Text] [Related]
20. Endothelin ETA receptor antagonist blocks cardiac hypertrophy provoked by hemodynamic overload.
Ito H; Hiroe M; Hirata Y; Fujisaki H; Adachi S; Akimoto H; Ohta Y; Marumo F
Circulation; 1994 May; 89(5):2198-203. PubMed ID: 8181145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
